| 1423- | Bos, | Acetyl-11-keto-β-Boswellic Acid Suppresses Invasion of Pancreatic Cancer Cells Through The Downregulation of CXCR4 Chemokine Receptor Expression |
| - | in-vitro, | Melanoma, | U266 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | SkBr3 | - | in-vitro, | PC, | PANC1 |
| 1424- | Bos, | Boswellia sacra essential oil induces tumor cell-specific apoptosis and suppresses tumor aggressiveness in cultured human breast cancer cells |
| - | in-vitro, | BC, | T47D | - | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
| 1425- | Bos, | Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2/HO-1 Defense Pathway |
| - | in-vivo, | Nor, | NA |
| 1426- | Bos, | CUR, | Chemo, | Novel evidence for curcumin and boswellic acid induced chemoprevention through regulation of miR-34a and miR-27a in colorectal cancer |
| - | in-vivo, | CRC, | NA | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | RKO | - | in-vitro, | CRC, | SW480 | - | in-vitro, | RCC, | SW-620 | - | in-vitro, | RCC, | HT-29 | - | in-vitro, | CRC, | Caco-2 |
| 1416- | Bos, | Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent |
| - | Review, | NA, | NA |
| 2024- | Bos, | Antiproliferative and cell cycle arrest potentials of 3-O-acetyl-11-keto-β-boswellic acid against MCF-7 cells in vitro |
| - | in-vitro, | BC, | MCF-7 | - | in-vitro, | Nor, | MCF10 |
| 1451- | Bos, | Phytochemical Analysis and Anti-cancer Investigation of Boswellia serrata Bioactive Constituents In Vitro |
| - | in-vitro, | CRC, | HepG2 | - | in-vitro, | CRC, | HCT116 |
| 1448- | Bos, | A triterpenediol from Boswellia serrata induces apoptosis through both the intrinsic and extrinsic apoptotic pathways in human leukemia HL-60 cells |
| - | in-vitro, | AML, | HL-60 |
| 1447- | Bos, | Boswellia carterii n-hexane extract suppresses breast cancer growth via induction of ferroptosis by downregulated GPX4 and upregulated transferrin |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF-7 | - | in-vivo, | BC, | 4T1 | - | in-vitro, | Nor, | MCF10 |
| 1449- | Bos, | Chemo, | Anti-proliferative, Pro-apoptotic, and Chemosensitizing Potential of 3-Acetyl-11-keto-β-boswellic Acid (AKBA) Against Prostate Cancer Cells |
| - | in-vitro, | Pca, | PC3 |
| - | in-vitro, | Pca, | DU145 |
| 5648- | BP, | Combined photothermal and sonodynamic therapy using a 2D black phosphorus nanosheets loaded coating for efficient bacterial inhibition and bone-implant integration |
| - | in-vivo, | Nor, | NA |
| 5647- | BP, | Black Phosphorus Quantum Dots Enhance the Radiosensitivity of Human Renal Cell Carcinoma Cells through Inhibition of DNA-PKcs Kinase |
| - | in-vitro, | RCC, | NA |
| 5646- | BP, | Black Phosphorus, an Emerging Versatile Nanoplatform for Cancer Immunotherapy |
| - | Review, | Var, | NA |
| 5645- | BP, | Accumulation, distribution, and toxicity of black phosphorus nanomaterials across biological systems: a critical review |
| - | Review, | Var, | NA |
| 5695- | BRU, | Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism |
| - | in-vitro, | Lung, | A549 |
| 5691- | BRU, | Brusatol Inhibits Proliferation, Migration, and Invasion of Nonsmall Cell Lung Cancer PC-9 Cells |
| - | in-vitro, | Lung, | PC9 | - | in-vitro, | Lung, | H1975 |
| 5693- | BRU, | Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2 |
| - | in-vivo, | HCC, | NA |
| 5694- | BRU, | Brusatol overcomes chemoresistance through inhibition of protein translation |
| - | in-vitro, | Lung, | A549 |
| 5696- | BRU, | The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer |
| - | in-vitro, | CRC, | HCT116 |
| 5697- | BRU, | Brusatol, a Nrf2 Inhibitor Targets STAT3 Signaling Cascade in Head and Neck Squamous Cell Carcinoma |
| - | in-vitro, | HNSCC, | NA |
| 5698- | BRU, | Brusatol suppresses STAT3-driven metastasis by downregulating epithelial-mesenchymal transition in hepatocellular carcinoma |
| - | in-vitro, | HCC, | NA |
| 5699- | BRU, | BJ, | Identification of the Brucea javanica Constituent Brusatol as a EGFR-Tyrosine Kinase Inhibitor in a Cell-Free Assay |
| - | in-vitro, | Lung, | A549 |
| 5700- | BRU, | Brusatol modulates the Nrf2/GCLC pathway to enhance ferroptosis in the treatment of oral squamous cell carcinoma |
| - | in-vitro, | Oral, | CAL27 |
| 5704- | BRU, | Brusatol ameliorates psoriatic dyslipidemia by targeting IL-1β to restore AMPK-mediated lipid homeostasis |
| - | in-vivo, | PSA, | HaCaT |
| 5703- | BRU, | Brusatol Enhances the Radiosensitivity of A549 Cells by Promoting ROS Production and Enhancing DNA Damage |
| - | in-vitro, | Lung, | H1299 | - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H460 |
| 5702- | BRU, | BJ, | Brusatol inhibits metastasis of triple-negative breast cancer through metabolic reprogramming |
| - | in-vitro, | BC, | NA |
| 5701- | BRU, | Brusatol induced ferroptosis in osteosarcoma cells by modulating the Keap1/Nrf2/SLC7A11 signaling pathway |
| - | in-vitro, | OS, | NA |
| 5707- | Brut, | Targeting Redox Homeostasis and Cell Survival Signaling with a Flavonoid-Rich Extract of Bergamot Juice in In Vitro and In Vivo Colorectal Cancer Models |
| - | in-vitro, | CRC, | HCT116 |
| 5706- | Brut, | Bergamot juice extract inhibits proliferation by inducing apoptosis in human colon cancer cells |
| - | in-vitro, | CRC, | HT29 |
| 5714- | Brut, | Probable Interaction of Bergamottin and Cyclosporine in a Lung Transplant Recipient |
| - | Case Report, | Nor, | NA |
| - | Review, | Nor, | NA |
| 5712- | Brut, | The anti-inflammatory and antioxidant effects of bergamot juice extract (BJe) in an experimental model of inflammatory bowel disease |
| - | in-vivo, | IBD, | NA |
| 5711- | Brut, | Citrus bergamia powder: Antioxidant, antimicrobial and anti-inflammatory properties |
| - | in-vitro, | Nor, | HMEC |
| 5705- | Brut, | A flavonoid-rich extract from bergamot juice prevents carcinogenesis in a genetic model of colorectal cancer, the Pirc rat (F344/NTac-Apcam1137) |
| - | in-vivo, | CRC, | NA |
| 5710- | Brut, | Recycling of Industrial Essential Oil Waste. Brutieridin and Melitidin, two Anticholesterolaemic Active Principles from Bergamot Albedo |
| - | Review, | Nor, | NA |
| 5709- | Brut, | Mechanisms Underlying the Anti-Tumoral Effects of Citrus bergamia Juice |
| - | in-vitro, | neuroblastoma, | SH-SY5Y |
| 5708- | Brut, | Clinical application of bergamot (Citrus bergamia) for reducing high cholesterol and cardiovascular disease markers |
| - | Review, | Nor, | NA |
| 6547- | BSB, | Antitumor effects of a-bisabolol against pancreatic cancer |
| - | vitro+vivo, | PC, | PANC1 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | PC, | KLM1 | - | in-vitro, | PC, | KP4 | - | in-vitro, | Nor, | ACBRI515 |
| 6542- | BSB, | Health Benefits, Pharmacological Effects, Molecular Mechanisms, and Therapeutic Potential of α-Bisabolol |
| - | Review, | Var, | NA | - | Review, | Park, | NA | - | Review, | AD, | NA |
| 6543- | BSB, | alpha-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells |
| - | in-vitro, | GBM, | U87MG |
| 6544- | BSB, | Involvement of mitochondrial permeability transition pore opening in alpha-bisabolol induced apoptosis |
| - | in-vitro, | GBM, | NA |
| 6545- | BSB, | The antineoplastic agent α-bisabolol promotes cell death by inducing pores in mitochondria and lysosomes |
| 6546- | BSB, | α-Bisabolol Inhibits Invasiveness and Motility in Pancreatic Cancer Through KISS1R Activation |
| - | in-vitro, | PC, | NA |
| - | in-vitro, | NSCLC, | A549 |
| 6549- | BSB, | (-)-α-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice |
| - | in-vivo, | Nor, | NA |
| 6550- | BSB, | α-bisabolol β-D-fucopyranoside as a potential modulator of β-amyloid peptide induced neurotoxicity: An in vitro &in silico study |
| - | in-vivo, | AD, | NA |
| 6551- | BSB, | α-bisabolol β-d-fucopyranoside (ABFP) ameliorates scopolamine-induced memory deficits through cholinesterase inhibition and attenuation of oxidative stress in zebrafish (Danio rerio) |
| - | in-vivo, | AD, | NA |
| 6552- | BSB, | Biochemical characterization of chamomile essential oil: Antioxidant, antibacterial, anticancer and neuroprotective activity and potential treatment for Alzheimer's disease |
| - | in-vivo, | AD, | NA |
| 6553- | BSB, | Pharmacological and biological effects of alpha-bisabolol: An updated review of the molecular mechanisms |
| - | Review, | Nor, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid